Clinical trials
Angina, Unstable trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2008 | 1 |
| 2010 | 2 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 15 |
| Completed | 12 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking University First Hospital | 3 |
| Sino Medical Sciences Technology Inc. | 2 |
| Amgen | 1 |
| AstraZeneca | 1 |
| Beijing Anzhen Hospital | 1 |
| Beijing Institute of Heart, Lung and Blood Vessel Diseases | 1 |
| Central South University | 1 |
| China Academy of Chinese Medical Sciences | 1 |
| Chinese PLA General Hospital | 1 |
| First Affiliated Hospital of Xinjiang Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Angina, Unstable | 32 |
| Angina, Stable | 7 |
| Acute Coronary Syndrome | 6 |
| Coronary Artery Disease | 6 |
| Myocardial Infarction | 6 |
| Coronary Disease | 4 |
| Neointima | 3 |
| ST Elevation Myocardial Infarction | 3 |
| Cardiovascular Diseases | 2 |
| Myocardial Ischemia | 2 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.